Energy News / Shareholders Foundation, Inc.

NASDAQ: HRTX Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Heron Therapeutics, Inc.

Via: ReleaseWire

Updated 10:14 AM CDT, Tue, October 29,2019

An investigation on behalf of current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ: HRTX stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 10/29/2019 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Heron Therapeutics, Inc..

Investors who are current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: HRTX stocks follows a lawsuit filed against Heron Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: HRTX stocks, concerns whether certain Heron Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Heron had failed to include adequate Chemistry, Manufacturing, and Controls ("CMC") and non-clinical information in its NDA for HTX-011, that the foregoing increased the likelihood that the FDA would not approve Heron's NDA for HTX-011, and that as a result, Heron's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-hrtx-long-term-shareholder-notice-investigation-of-potential-wrongdoing-at-heron-therapeutics-inc-1263633.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com